Navigation Links
Valeant Pharmaceuticals Congratulates Teva and Cephalon on Their Transaction
Date:5/2/2011

MISSISSAUGA, Ontario, May 2, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today congratulated Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Cephalon, Inc. (NASADQ: CEPH) on their announcement that Cephalon has agreed to be acquired by Teva.  In response to the news, Valeant has withdrawn its consent solicitation.

"We believe that this announcement is positive news for Cephalon stockholders and we are pleased that Teva has paid what we believe is a very full value for the company and as a result, have withdrawn our consent solicitation," stated J. Michael Pearson, chairman and chief executive officer.  "As Cephalon stockholders ourselves with over a million shares owned, we will benefit from this transaction without participating further in the process.  We will remain disciplined on our M&A strategy and will look to deploy our freed-up capital on other opportunities to create value for our shareholders."

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant can be found at www.valeant.com.

Forward-looking Statements

This press release may contain forward-looking statements, including, but not limited to, statements regarding Valeant's expectation to benefit from the proposed acquisition of Cephalon by Teva and opportunities to create value for Valeant shareholders. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Valeant Pharmaceuticals to Announce 2011 First Quarter Results on May 9, 2011
2. Valeant Pharmaceuticals Responds to Cephalon Boards Letter
3. Valeant Pharmaceuticals Announces Redemption of 4.0% Convertible Subordinated Notes Due 2013
4. Regulatory Update - GSK and Valeant Respond to FDA on ezogabine
5. Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors
6. Valeant Pharmaceuticals Files Presentation for Cephalon Stockholders
7. Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
8. Promius Pharma and Valeant Form Collaboration to Market Cloderm® Cream in the United States
9. Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash
10. GSK and Valeant Receive European Authorisation for Trobalt (retigabine)
11. Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... CINCINNATI , May 21, 2013  LCA-Vision Inc. (NASDAQ: ... correction services under the Lasik Plus ® brand, announces that ... to one-year terms at today,s annual meeting of stockholders.  These ... , co-founder and President of Bahl & Gaynor Investment Counsel ... with BSC Ventures , Edgar F. Heizer ...
(Date:5/21/2013)... , May 21, 2013  Decision Resources, ... advisory firms for pharmaceutical and healthcare issues, ... agent on key efficacy endpoints, including overall ... the most influence over surveyed U.S. and ... (HR-) positive, HER2-negative breast cancer. The two ...
(Date:5/21/2013)... 2013 Hurel Corporation ("Hurel"), a world-leading provider ... platforms, today announced the appointment of James ... Board of Directors. Dr. MacDonald is the former Executive ... Institute ("SPRI"), which was the pharmaceutical development arm of ... Co. in 2009. Over a career that ...
Breaking Medicine Technology:LCA-Vision Reports on Annual Meeting of Stockholders 2LCA-Vision Reports on Annual Meeting of Stockholders 3LCA-Vision Reports on Annual Meeting of Stockholders 4Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2
... ALCAT Test to help chronic symptoms such as obesity, ... Medical researchers from Dubai today reported in the April ... Medicine (The Effect of The ALCAT Test Diet Therapy ... unable to achieve goal weight loss by calorie restriction ...
... PAUL, Minn., April 3 Torax Medical Inc., a ... of gastroesophageal reflux disease (GERD) has commenced a pivotal ... The trial, which is being conducted at 15 leading ... Europe, will evaluate the safety and effectiveness of the ...
Cached Medicine Technology:Study Confirms: Your Hidden Food Allergies Are Making You Fat 2Study Confirms: Your Hidden Food Allergies Are Making You Fat 3Torax Medical Launches Pivotal Clinical Study of New Acid Reflux Treatment 2
(Date:5/21/2013)... Atlanta, GA (PRWEB) May 21, 2013 Patients ... Dental Care who have lost teeth due to gum disease ... traditional surgery for gum disease treatment with laser gum ... implants, which have the highest success rate out of all ... Procedure (LANAP) is a relatively new procedure cleared by the ...
(Date:5/21/2013)... May 21, 2013 ContinuCare Home Health, ... Department of Aging and Disability Services. After completing a ... interviews, ContinuCare Home Health was found to have ... is part of the Department of Aging and Disability ... and disability services, supports and opportunities that are ...
(Date:5/21/2013)... 21 May 2013, Paris, France: One-year results from SOURCE ... valve implantation (TAVI) registries to-date reported today at ... practice, with high rates of device success for all ... SOURCE XT Post-Approval Study followed up 2688 consecutively enrolled ... Sapien XT heart valve at 93 centres in 17 ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 The ... on cable networks and cable channels across the country, ... on its YouTube channel. The producers of the series ... in the shipping industry, the manufacturing industry, health-related companies, ... medical facilities and medical practitioners in all parts of ...
(Date:5/21/2013)... Texas (PRWEB) May 21, 2013 ... With the help of Texas Counseling’s Sexuality and ... communication, and the development of healthier habits for ... workshops available for both couples and individuals at ... enhance their relationships and learn skills to develop ...
Breaking Medicine News(10 mins):Health News:Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA 2Health News:ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services 2Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2Health News:Workshops Offered To Identify Underlying Challenges That Put Strain On Relationships 2
... OmniPod(R) Insulin Management System Lets Cyclists Focus on Winning ... June 26 Today, Team Type 1 concluded the ... first-place in the 8-person team category division. In this ... and ending in Annapolis, MD, Team Type 1 members ...
... Today Sentry Data Systems, Inc. announced Claims Guardian(TM), ... Revenue Cycle Management application. Claims Guardian is designed ... for unusual, missing, or errant charges that may affect ... "We believe that automatically matching actual procurement activity to ...
... ... on searchhearthealth.com, a new informational Web site devoted to all aspects of heart health. ... Potomac, MD (Vocus) June 26, ... is now a featured expert on searchhearthealth.com, a new informational Web site devoted to all ...
... ... largest nationally recognized physician multi-specialty certifying organization , has formed the American Board ... ... Physician Specialties (ABPS) today announced the formation of the American Board of Family Medicine ...
... , SHANGHAI, June 25 /PRNewswire-Asia/ ... today announced that it filed its annual report on ... the Securities and Exchange Commission. The,annual report can be ... the Investor Relations section. WuXi,PharmaTech will provide a hard ...
... A U.S. District Court judge issued an injunction Thursday ... cut in wages for the state,s 400,000 home care workers. The ... counties that were planning on passing the state cut through to ... by federal judge Claudia Wilken, was in response to a lawsuit ...
Cached Medicine News:Health News:Team Type 1 Takes First Place Finish in Race Across America 2Health News:Team Type 1 Takes First Place Finish in Race Across America 3Health News:Sentry Data Systems Announces Claims Guardian(TM) 2Health News:Sentry Data Systems Announces Claims Guardian(TM) 3Health News:Dr. David Williams Featured on Searchhearthealth.com 2Health News:American Board of Family Medicine Obstetrics Formed 2Health News:WuXi PharmaTech Files 2008 Annual Report on Form 20-F 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: